BAYESIAN HIERARCHICAL MODELING OF RANDOMIZED AND NON-RANDOMIZED STUDIES COMPARING CICLOSPORIN WITH IMMEDIATE- AND PROLONGED-RELEASE TACROLIMUS IN LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Muduma, G. [1 ]
Pollock, R. F. [2 ]
Odeyemi, I. A. [1 ]
Saunders, R. [2 ]
机构：
[1] Astellas Pharma EMEA, Chertsey, England
[2] Ossian Hlth Econ & Commun GmbH, Basel, Switzerland
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI2
引用
收藏
页码：A222 / A222
页数：1
相关论文
共 50 条
  • [31] A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study
    Dumortier, Jerome
    Duvoux, Christophe
    Dubel, Laurence
    Bazin, Fabienne
    Houssel-Debry, Pauline
    ANNALS OF TRANSPLANTATION, 2019, 24 : 506 - 516
  • [32] Safety and Efficacy Conversion from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Adavagraf) in Stable Liver Transplant Recipients
    Li, Chiu-Yen
    Wu, Chih-I
    Chen, Yao-Li
    Ng, Sock-Ping
    Chien, Su-Yu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 74 - 74
  • [33] A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes
    Riegersperger, Markus
    Plischke, Max
    Jallitsch-Halper, Anita
    Steinhauser, Corinna
    Foedinger, Manuela
    Winkelmayer, Wolfgang C.
    Dunkler, Daniela
    Sunder-Plassmann, Gere
    PLOS ONE, 2019, 14 (07):
  • [34] Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
    Nassim Kamar
    Elisabeth Cassuto
    Giovanni Piotti
    Mirco Govoni
    Giorgia Ciurlia
    Silvia Geraci
    Gianluigi Poli
    Gabriele Nicolini
    Christophe Mariat
    Marie Essig
    Paolo Malvezzi
    Yannick Le Meur
    Valerie Garrigue
    Arnaud Del Bello
    Lionel Rostaing
    Advances in Therapy, 2019, 36 : 462 - 477
  • [35] COSMOS: A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE IV STUDY OF KIDNEY TRANSPLANT PATIENTS CONVERTED FROM CICLOSPORIN TO PROLONGED-RELEASE TACROLIMUS PLUS STANDARD OR REDUCED-DOSE CORTICOSTEROIDS
    Baek, Chung Hee
    Kim, Chan-Duck
    Lee, Dong Ryeol
    Kim, Yeong Hoon
    Yang, Jaeseok
    Kim, Beom Seok
    Lee, Jong Soo
    Han, Sang Youb
    Kim, Soo Wan
    Lee, Sik
    Lee, Kang Wook
    Kong, Jin Min
    Shin, Byung Chul
    Lee, Sang Ho
    Chae, Dong Wan
    Kwon, Young Joo
    Park, Su-Kil
    TRANSPLANT INTERNATIONAL, 2017, 30 : 250 - 251
  • [36] Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
    Kamar, Nassim
    Cassuto, Elisabeth
    Piotti, Giovanni
    Govoni, Mirco
    Ciurlia, Giorgia
    Geraci, Silvia
    Poli, Gianluigi
    Nicolini, Gabriele
    Mariat, Christophe
    Essig, Marie
    Malvezzi, Paolo
    Le Meur, Yannick
    Garrigue, Valerie
    Del Bello, Arnaud
    Rostaing, Lionel
    ADVANCES IN THERAPY, 2019, 36 (02) : 462 - 477
  • [37] A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients
    Herden, Uta
    Sterneck, Martina
    Buchholz, Bettina M.
    Achilles, Eike G.
    Ott, Armin
    Fischer, Lutz
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1771 - 1780
  • [38] Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial
    Verma, Manisha
    Zaki, Radi
    Sadeh, Johnathan
    Knorr, John P.
    Gallagher, Mark
    Parsikia, Afshin
    Navarro, Victor
    JOURNAL OF TRANSPLANTATION, 2023, 2023
  • [39] ADHERENCE AND DE NOVO DONOR-SPECIFIC ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS: IMPLICATIONS FOR CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH PROLONGED-RELEASE AND IMMEDIATE-RELEASE TACROLIMUS IN CANADA
    Pollock, R. F.
    Schwartz, J.
    Howell, J.
    VALUE IN HEALTH, 2017, 20 (05) : A308 - A309
  • [40] A Randomized, Single-Center Trial Comparing Thymoglobulin (TG) Induction Therapy and Delayed Initiation of Tacrolimus to No Induction with Immediate Initiation of Tacrolimus in Liver Transplant (LT) Recipients To Assess the Impact on Renal Function
    Grant, W.
    Botha, J.
    Mercer, D.
    Olivera-Martinez, M.
    McCashland, T.
    Langnas, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 539 - 539
12345